Details for New Drug Application (NDA): 062718
✉ Email this page to a colleague
The generic ingredient in OMNIPEN-N is ampicillin sodium. There are seventy drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
Summary for 062718
Tradename: | OMNIPEN-N |
Applicant: | Wyeth Ayerst |
Ingredient: | ampicillin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 062718
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 125MG BASE/VIAL | ||||
Approval Date: | Dec 16, 1986 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/VIAL | ||||
Approval Date: | Dec 16, 1986 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Dec 16, 1986 | TE: | RLD: | No |
Complete Access Available with Subscription